Trial Profile
A phase 1 clinical study of WT2725 in patients with advanced solid malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs WT 2725 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Sumitomo Dainippon Pharma
- 02 Nov 2015 New trial record